GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 15 filers reported holding GW PHARMACEUTICALS PLC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $277,393,000 | +817.5% | 1,278,900 | +411.6% | 1.38% | +315.1% |
| Q1 2017 | $30,235,000 | +82.9% | 250,000 | +69.0% | 0.33% | +74.7% |
| Q4 2016 | $16,531,000 | +301.7% | 147,928 | +377.2% | 0.19% | +216.7% |
| Q3 2016 | $4,115,000 | +12.3% | 31,000 | -22.5% | 0.06% | +20.0% |
| Q2 2016 | $3,663,000 | -15.4% | 40,000 | -33.3% | 0.05% | +22.0% |
| Q1 2016 | $4,329,000 | -41.3% | 60,000 | 0.0% | 0.04% | -58.6% |
| Q2 2015 | $7,370,000 | -62.6% | 60,000 | -75.4% | 0.10% | -68.7% |
| Q3 2014 | $19,727,000 | -47.8% | 244,000 | -30.8% | 0.32% | -42.1% |
| Q2 2014 | $37,820,000 | -4.1% | 352,500 | -46.9% | 0.55% | -29.5% |
| Q1 2014 | $39,422,000 | +62.5% | 664,000 | +13.7% | 0.77% | +54.2% |
| Q4 2013 | $24,259,000 | +139.5% | 584,000 | 0.0% | 0.50% | +141.3% |
| Q3 2013 | $10,127,000 | +105.2% | 584,000 | +4.3% | 0.21% | +118.9% |
| Q2 2013 | $4,934,000 | – | 560,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 311,853 | $21,655,000 | 13.09% |
| Lamond Capital Partners LLC | 120,000 | $10,964,000 | 5.47% |
| GREAT POINT PARTNERS LLC | 100,000 | $6,944,000 | 2.91% |
| Perceptive Advisors | 400,000 | $27,776,000 | 2.06% |
| Iguana Healthcare Management, LLC | 60,687 | $4,214,000 | 1.39% |
| DIALECTIC CAPITAL MANAGEMENT, LP | 46,000 | $3,195,000 | 0.92% |
| FT Options LLC | 51,300 | $1,191,000 | 0.88% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 310,122 | $21,535,000 | 0.87% |
| Folger Hill Asset Management LP | 176,033 | $12,224,000 | 0.74% |
| CLOUGH CAPITAL PARTNERS L P | 220,276 | $15,296,000 | 0.72% |